User:Mssciguy/sandbox/Afrezza

''Afrezza is a drug-device combination product that consists of a dry formulation of human insulin delivered from a small and portable inhaler to help patients achieve blood sugar control. Afrezza is rapidly absorbed and has a short duration of action. It is administered at the beginning of a meal. Afrezza can help control high blood sugar as part of a diabetes management plan that may include diet, exercise and other diabetes medications.

Afrezza should not be used in patients with chronic lung disease such as asthma or COPD. Afrezza cannot be used to treat diabetic ketoacidosis. Afrezza is not recommended in patients who smoke or who have recently stopped smoking. '' new article content ...